A nine country study of the burden of non‐severe nocturnal hypoglycaemic events on diabetes management and daily function-Reference-Cited by-同舟云学术

A nine country study of the burden of non‐severe nocturnal hypoglycaemic events on diabetes management and daily function

Published:2013-02-25 Issue:6 Volume:15 Page:546-557
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Brod M.¹,Wolden M.²,Christensen T.²,Bushnell D. M.³

Affiliation:

1. The Brod Group Mill Valley CA USA

2. Novo Nordisk A/S Soeborg Denmark

3. Health Research Associates, Inc. Mountlake Terrace WA USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12070

Reference22 articles.

1. GAPP2™: global survey finds in the last month one in four type 2 diabetes patients do not take basal insulin as prescribed and over a third suffer hypoglycaemia;Brod M;Diabetes,2012

2. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

3. Assessment of the impact of fear of hypoglycemic episodes on hypoglycemia management and glucose control management;Leiter L;Can J Diabetes,2005

4. Uncovering undetected hypoglycemic events

5. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring;Journal of Diabetes Science and Technology;2024-08-19

2. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

3. Factors and economic burden of non-severe hypoglycemia among insulin-treated type 2 diabetes patients: a cross-sectional study;Current Medical Research and Opinion;2024-02-12

4. Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor;Diabetes Technology & Therapeutics;2023-09-01

5. Construction and Evaluation of a Protocol to Support the Prescription of Glucagon Nasal Powder during Educational Hospitalization in Patients with Diabetes;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2023-03-10